Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 301–400 of 1,004
Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension
Cartin‐Ceba, R., Burger, C. D., Swanson, K. L., Vargas, H. E., Aqel, B. A., Keaveny, A. P., Heimbach, J. K., Taner, T., Nyberg, S. L., Rosen, C. B. B., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003490 · Cited by 53
Self-citationPulmonary Hypertension in 2021: Part I—Definition, Classification, Pathophysiology, and Presentation
Gelzinis, T. A. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.06.036 · Cited by 53
Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
Alhamad, E. H., Cal, J. G., Alrajhi, N. N., & Alharbi, W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123828 · Cited by 52
Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment
Mukherjee, D., & Konduri, G. G. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200023 · Cited by 52
Zhang, Q., Zhu, F., Shi, G., Hu, C., Zhang, W., Huang, P., Zhu, C., Gu, H., Yang, D. L., Li, Q., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.057987 · Cited by 52
Dave, J. K., Jagana, V., Janoštiak, R., & Bisserier, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04339-5 · Cited by 52
Balasubramanian, A., Kolb, T. M., Damico, R. L., Hassoun, P. M., McCormack, M. C., & Mathai, S. C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.047 · Cited by 52
Atualização no Tratamento da Hipertensão Arterial Pulmonar
Fernandes, C. J. C. D. S., Calderaro, D., Assad, A. P. L., Salibe-Filho, W., Morinaga, L. T. K., Hoette, S., Piloto, B. M., Castro, M. A., Lisboa, R. P., da Silva, T. A. F., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200702 · Cited by 52
Self-citationKaria, N., Howard, L., Johnson, M., Kiely, D. G., Lordan, J. L., McCabe, C., Pepke‐Żaba, J., Ong, R. C.-Y., Preiß, M., Knight, D. S., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad532 · Cited by 51
Pulmonary arterial hypertension: Sex matters
Dignam, J. P., Sharma, S., Stasinopoulos, I. A., & MacLean, M. R. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16277 · Cited by 51
State-of-the-Art Review: Echocardiography in Pulmonary Hypertension
Cordina, R., Playford, D. A., Lang, I. M., & Celermajer, D. S. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.03.003 · Cited by 51
Self-citationPulmonary Hypertension Associated with Connective Tissue Disease
Fayed, H., & Coghlan, G. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1685214 · Cited by 51
Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra
Rajagopal, K., Bryant, A. J., Sahay, S., Wareing, N. E., Zhou, Y., Pandit, L. M., & Karmouty‐Quintana, H. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15036 · Cited by 51
Favorable Pregnancy Outcomes in Women With Well-Controlled Pulmonary Arterial Hypertension
Corbach, N., Berlier, C., Lichtblau, M., Schwarz, E. I., Gautschi, F., Groth, A., Schüpbach, R., Krähenmann, F., Saxer, S., & Ulrich, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.689764 · Cited by 51
An emerging phenotype of pulmonary arterial hypertension patients carryingSOX17variants
Montani, D., Lechartier, B., Girerd, B., Eyries, M., Ghigna, M., Savale, L., Jaïs, X., Seferian, A., Jevnikar, M., Boucly, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00656-2022 · Cited by 51
Self-citationTang, B., Liu, Y., Zhang, J., Lü, M., & Wang, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114920 · Cited by 50
The Right Ventricle—You May Forget It, But It Will Not Forget You
Wanner, P. M., & Filipovic, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020432 · Cited by 50
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
Ribeuz, H. L., Capuano, V., Girerd, B., Humbert, M. J. C., Montani, D., & Antigny, F. (2020) · Biomolecules · doi:10.3390/biom10091261 · Cited by 50
Self-citationPredicting mortality during long-term follow-up in pulmonary arterial hypertension
Kylhammar, D., Hjalmarsson, C., Hesselstrand, R., Jansson, K., Kavianipour, M., Kjellström, B., Nisell, M., Söderberg, S., & Rådegran, G. (2021) · ERJ Open Research · doi:10.1183/23120541.00837-2020 · Cited by 50
Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension
Richter, M. J., Hsu, S., Yogeswaran, A., Husain‐Syed, F., Vadász, I., Ghofrani, H. A., Naeije, R., Harth, S., Grimminger, F., Seeger, W., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00583.2020 · Cited by 50
Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension
Liang, S., Desai, A. A., Black, S. M., & Tang, H. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63046-1_15 · Cited by 50
Sánchez-Gloria, J. L., Carbó, R., Buelna‐Chontal, M., Osorio‐Alonso, H., Hernández-Díazcouder, A., de la Fuente-León, R. L., Sandoval, J., Sánchez‐Muñoz, F., Rubio‐Gayosso, I., & Sánchez‐Muñoz, F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120091 · Cited by 50
Pulmonary hypertension and valvular heart disease
Tichelbäcker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wißmüller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., et al. (2019) · Herz · doi:10.1007/s00059-019-4823-6 · Cited by 49
Pulmonary artery involvement in Takayasu’s arteritis: diagnosis before pulmonary hypertension
Yang, J., Peng, M., Shi, J., Zheng, W., & Yu, X. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0983-7 · Cited by 49
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
Revercomb, L., Hanmandlu, A., Wareing, N. E., Akkanti, B. H., & Karmouty‐Quintana, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.624093 · Cited by 49
Sex Differences in Right Ventricular Dysfunction: Insights From the Bench to Bedside
Keen, J. L., Prisco, S. Z., & Prins, K. W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.623129 · Cited by 49
Chubuchny, V., Pugliese, N. R., Taddei, C., Poggianti, E., Spini, V., Barison, A., Formichi, B. A., Airò, E., Bauleo, C., Prediletto, R., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13183 · Cited by 49
Nathan, S. D., Barnett, S. D., King, C. S., Provencher, S., Barberà, J. A., Pastré, J., Shlobin, O. A., & Seeger, W. (2021) · Pulmonary Circulation · doi:10.1177/2045894021999960 · Cited by 49
Young, A., Moles, V., Jaafar, S., Visovatti, S., Huang, S., Vummidi, D. R., Nagaraja, V., McLaughlin, V. V., & Khanna, D. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41732 · Cited by 49
JCS/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases
Anzai, T., Sato, T., Fukumoto, Y., Izumi, C., Kizawa, Y., Koga, M., Nishimura, K., Ohishi, M., Sakashita, A., Sakata, Y., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-1127 · Cited by 49
Pregnancy and Pulmonary Hypertension
Mei, J. Y., Channick, R. N., & Afshar, Y. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.08.019 · Cited by 48
Kucherenko, M. M., Sang, P., Yao, J., Gransar, T., Dhital, S., Grune, J., Simmons, S., Michalick, L., Wulsten, D., Thiele, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39934-z · Cited by 48
Tuder, R. M., Gandjeva, A., Williams, S., Kumar, S., Kheyfets, V. O., Hatton‐Jones, K. M., Starr, J. R., Yun, J. H., Hong, J. S., West, N. P., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202307-1310oc · Cited by 48
Hirani, N., Brunner, N. W., Kapasi, A., Chandy, G., Rudski, L., Paterson, D. I., Langleben, D., Mehta, S., & Mielniczuk, L. M. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.041 · Cited by 48
Yang, J., Griffiths, M., Nies, M., Brandal, S., Damico, R. L., Vaidya, D. M., Tao, X., Simpson, C. E., Kolb, T. M., Mathai, S. C., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01734-3 · Cited by 48
Wang, L., Zhang, X., Cao, Y., Ma, Q., Mao, X., Xu, J., Yang, Q., Zhou, Y., Lucas, R., Fulton, D. J., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15339 · Cited by 48
Pulmonary hypertension in aortic valve stenosis
Maeder, M. T., Weber, L., & Rickli, H. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.12.005 · Cited by 48
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.11.026 · Cited by 47
Connective tissue disease‐associated pulmonary hypertension: A comprehensive review
Khangoora, V. S., Bernstein, E. J., King, C. S., & Shlobin, O. A. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12276 · Cited by 47
Pulmonary Complications of Portal Hypertension
Cartin‐Ceba, R., & Krowka, M. J. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.06.003 · Cited by 47
Self-citationRegulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension
Huetsch, J., Suresh, K. S., & Shimoda, L. A. (2019) · Antioxidants · doi:10.3390/antiox8030056 · Cited by 47
Systemic sclerosis: Recent insight in clinical management
Zanatta, E., Codullo, V., Avouac, J., & Allanore, Y. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2019.09.015 · Cited by 47
Lipps, C., Northe, P., de Figueiredo, R. M., Rohde, M., Brahmer, A., Krämer‐Albers, E., Liebetrau, C., Wiedenroth, C. B., Mayer, E., Kriechbaum, S. D., et al. (2019) · Biomolecules · doi:10.3390/biom9110666 · Cited by 47
Vang, A., Bós, D. D. S. G., Fernández-Nicolas, A., Zhang, P., Morrison, A., Mancini, T. J., Clements, R., Polina, I. A., Cypress, M. W., Jhun, B. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.142945 · Cited by 47
Topyła, W., Tomaszewski, M., Wysokiński, A. P., & Tomaszewski, A. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153229 · Cited by 47
Dhoble, S., Patravale, V. B., Weaver, E., Lamprou, D. A., & Patravale, T. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121792 · Cited by 47
Deng, H., Tian, X., Sun, H., Liu, H., Lü, M., & Wang, H. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17295 · Cited by 47
Cytokines as prognostic biomarkers in pulmonary arterial hypertension
Boucly, A., Tu, L., Guignabert, C., Rhodes, C. J., de Groote, P., Prévôt, G., Bergot, E., BOURDIN, A. A., Beurnier, A., Roche, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01232-2022 · Cited by 47
Self-citationElectrocardiogram Detection of Pulmonary Hypertension Using Deep Learning
ARAS, M. A., ABREAU, S., MILLS, H., RADHAKRISHNAN, L., KLEIN, L., MANTRI, N., RUBIN, B., BARRIOS, J., CHEHOUD, C., KOGAN, E., et al. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.12.016 · Cited by 46
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
Almaaitah, S., Highland, K. B., & Tonelli, A. R. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s232038 · Cited by 46
Szulcek, R., Sánchez‐Duffhues, G., Rol, N., Pan, X., Tsonaka, R., Dickhoff, C., Yung, L., Manz, X. D., Kurakula, K., Kiełbasa, S. M., et al. (2020) · Angiogenesis · doi:10.1007/s10456-020-09741-x · Cited by 46
Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension
Welch, C. L., & Chung, W. K. (2020) · Genes · doi:10.3390/genes11101213 · Cited by 46
Right ventricle in heart failure with preserved ejection fraction
Berglund, F., Piña, P., & Herrera, C. J. (2020) · Heart · doi:10.1136/heartjnl-2020-317342 · Cited by 46
MR 4D flow-based mean pulmonary arterial pressure tracking in pulmonary hypertension
Reiter, U., Kovács, G., Reiter, C., Kräuter, C., Nizhnikava, V., Fuchsjäger, M., Olschewski, H., & Reiter, G. (2020) · European Radiology · doi:10.1007/s00330-020-07287-6 · Cited by 46
Matsunaga, K., Harada, M., Suizu, J., Oishi, K., Asami‐Noyama, M., & Hirano, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103078 · Cited by 46
Sun, Y., Lü, M., Sun, T.-R., & Wang, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15671 · Cited by 46
Plasma markers in pulmonary hypertension subgroups correlate with patient survival
Koudstaal, T., van Uden, D., van Hulst, J. A. C., Heukels, P., Bergen, I. M., Geenen, L. W., Baggen, V. J. M., van den Bosch, A. E., van den Toorn, L. M., Chandoesing, P. P., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01716-w · Cited by 46
Jiang, X., Zhu, Y., Zhou, Y., Peng, F.-H., Wang, L., Ma, W., Cao, Y., Pan, X., Zhang, G., Zhang, F., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab599 · Cited by 46
Liver abnormalities in pulmonary arterial hypertension
Nickel, N. P., Galura, G. M., Zuckerman, M. J., Hakim, M. N., Alkhateeb, H., Mukherjee, D., Austin, E. D., & Heresi, G. A. (2021) · Pulmonary Circulation · doi:10.1177/20458940211054304 · Cited by 46
Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension
Liang, S., Yegambaram, M., Wang, T., Wang, J., Black, S. M., & Tang, H. (2022) · Biomedicines · doi:10.3390/biomedicines10020341 · Cited by 46
Chronic Thromboembolic Pulmonary Hypertension
Teerapuncharoen, K., & Bag, R. (2022) · Lung · doi:10.1007/s00408-022-00539-w · Cited by 46
Khawar, M. U., Yazdani, D., Zhu, Z., Jandarov, R., Dilling, D. F., & Gupta, N. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.015 · Cited by 45
Wujak, M., Veith, C., Wu, C., Wilke, T., Kanbagli, Z. I., Novoyatleva, T., Günther, A., Seeger, W., Grimminger, F., Sommer, N., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910371 · Cited by 45
Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension
Poyatos, P., Gratacós, M., Samuel, K., Orriols, R., & Tura-Ceide, O. (2023) · Antioxidants · doi:10.3390/antiox12051006 · Cited by 45
Rio‐Pertuz, G. D., NUGENT, K. M., & Argueta‐Sosa, E. E. (2023) · PubMed Central · Cited by 45
A Fluid Challenge Test for the Diagnosis of Occult Heart Failure
D’Alto, M., Badesch, D. B., Bossone, E., Borlaug, B. A., Brittain, E. L., Humbert, M. J. C., & Naeije, R. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.08.019 · Cited by 45
Determinants and Management of the Post–Pulmonary Embolism Syndrome
Boon, G. J. A. M., Huisman, M. V., & Klok, F. A. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1722964 · Cited by 45
Sun, Y., Sangam, S., Guo, Q., Wang, J., Tang, H., Black, S. M., & Desai, A. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.719058 · Cited by 45
Presentation of Congenital Portosystemic Shunts in Children
Bahadori, A., Kuhlmann, B., Debray, D., Franchi‐Abella, S., Wacker, J., Beghetti, M., Wildhaber, B. E., McLin, V. A., & IRCPSS, O. B. O. T. (2022) · Children · doi:10.3390/children9020243 · Cited by 45
Molecular hydrogen is a promising therapeutic agent for pulmonary disease
Fu, Z., & Zhang, J. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100420 · Cited by 45
Ribeiro, T. P., Barbeau, S., Baudrimont, I., Vacher, P., Freund‐Michel, V., Cardouat, G., Berger, P., Guibert, C., Ducret, T., & Quignard, J. (2022) · Cells · doi:10.3390/cells11152349 · Cited by 45
Nikitopoulou, I., Manitsopoulos, N., Kotanidou, A., Tian, X., Petrovic, A., Magkou, C., Ninou, I., Aidinis, V., Schermuly, R. T., Kosanovic, D., et al. (2019) · Pulmonary Circulation · doi:10.1177/2045894019881954 · Cited by 44
Endothelin receptor antagonists for pulmonary arterial hypertension
Liu, C., Chen, J., Gao, Y., Deng, B., & Liu, K. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004434.pub6 · Cited by 44
Pulmonary vascular disease and pulmonary hypertension
Ghigna, M., & Dorfmüller, P. (2019) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2019.05.002 · Cited by 44
Pulmonary Hypertension in Interstitial Lung Disease
Ang, H. L., Schulte, M., Chan, R. K., Tan, H. H., Harrison, A., Ryerson, C. J., & Khor, Y. H. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.04.025 · Cited by 44
Rosenzweig, E. B., Gannon, W. D., Madahar, P., Agerstrand, C. L., Abrams, D. C., Liou, P., Brodie, D., & Bacchetta, M. D. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.09.004 · Cited by 44
DuBroff, J. J., Melendres-Groves, L. D., Lin, Y., Beene, D., & Ketai, L. H. (2019) · Pulmonary Circulation · doi:10.1177/2045894019894534 · Cited by 44
Farrell, A. T., Panepinto, J. A., Desai, A. A., Kassim, A. A., Lebensburger, J. D., Walters, M. C., Bauer, D. E., Blaylark, R. M., DiMichele, D., Gladwin, M. T., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000883 · Cited by 44
Fretheim, H., Halse, A., Seip, M., Bitter, H., Wallenius, M., Garen, T., Salberg, A., Brunborg, C., Midtvedt, Ø., Molberg, Ø., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa026 · Cited by 44
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension
Zhang, C., Zhang, T., Lu, W., Duan, X., Luo, X., Liu, S., Chen, Y., Li, Y., Chen, J., Liao, J., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15025 · Cited by 44
Dunmore, B. J., Jones, R. J., Toshner, M. R., Upton, P. D., & Morrell, N. W. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa350 · Cited by 44
Crespo, M. M., Lease, E. D., Solé, A., Sandorfi, N., Snyder, L. D., Berry, G. J., Pavec, J. L., Venado, A. E., Martínez, J. M. C., Goldberg, H. J., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.014 · Cited by 44
Treatment of pulmonary hypertension associated with COPD: a systematic review
Arif, R., Pandey, A. K., Zhao, Y., Arsenault‐Mehta, K., Khoujah, D., & Mehta, S. (2021) · ERJ Open Research · doi:10.1183/23120541.00348-2021 · Cited by 44
Berlier, C., Saxer, S., Lichtblau, M., Schneider, S., Schwarz, E. I., Furian, M., Bloch, K. E., Carta, A. F., & Ulrich, S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023839 · Cited by 44
Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension
Hidalgo, D. C., Elajaili, H. B., Suliman, H. B., George, M. P., Delaney, C. A., & Nozik‐Grayck, E. (2022) · Antioxidants · doi:10.3390/antiox11020428 · Cited by 44
Drugs of Misuse: Focus on Vascular Dysfunction
Middlekauff, H. R., Cooper, Z. D., & Strauss, S. B. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.04.011 · Cited by 44
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
Montani, D., Certain, M. C., Weatherald, J. C., Jaïs, X., Bulifon, S., Noël‐Savina, E., Nieves, A., Renard, S., Traclet, J., Bouvaist, H., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2761oc · Cited by 44
Self-citationPericytes: The lung-forgotten cell type
Garrison, A. T., Bignold, R. E., Wu, X., & Johnson, J. R. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1150028 · Cited by 44
Kosyakovsky, L. B., Liu, E. E., Wang, J. K., Myers, L., Parekh, J. K., Knauss, H., Lewis, G. D., Malhotra, R., Nayor, M., Robbins, J. M., et al. (2024) · Circulation: Heart Failure · doi:10.1161/circheartfailure.123.011366 · Cited by 43
Emerging multimodality imaging techniques for the pulmonary circulation
Rajagopal, S., Bogaard, H. J., Elbaz, M. S. M., Freed, B. H., Rémy‐Jardin, M., van Beek, E. J. R., Gopalan, D., & Kiely, D. G. (2024) · European Respiratory Journal · doi:10.1183/13993003.01128-2024 · Cited by 43
Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center
Pi, H., Kosanovich, C. M., Handen, A. L., Tao, M., Visina, J., Vanspeybroeck, G., Simon, M. A. M., Risbano, M. G., Desai, A., Mathier, M. A., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.046 · Cited by 43
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis
Schoenberg, N. C., Argula, R. G., Klings, E. S., Wilson, K. C., & Farber, H. W. (2020) · Lung · doi:10.1007/s00408-020-00355-0 · Cited by 43
Hypoxia‐induced pulmonary hypertension—Utilizing experiments of nature
Gassmann, M., Cowburn, A. S., Gu, H., Li, J., Rodriguez, M., Babicheva, A., Jain, P., Xiong, M., Gassmann, N. N., Yuan, J. X. ‐., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15144 · Cited by 43
Diagnosis and treatment of right ventricular dysfunction in congenital heart disease
Santens, B., Bruaene, A. V. D., Meester, P. D., D’Alto, M., Reddy, S., Bernstein, D., Köestenberger, M., Hansmann, G., & Budts, W. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-370 · Cited by 43
Richter, M. J., Yogeswaran, A., Husain‐Syed, F., Vadász, I., Rako, Z. A., Mohajerani, E., Ghofrani, H. A., Naeije, R., Seeger, W., Herberg, U., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab038 · Cited by 43
Mondéjar‐Parreño, G., Cogolludo, A. L., & Pérez‐Vizcaíno, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107835 · Cited by 43
Takita, Y., Takeda, Y., Fujisawa, D., Kataoka, M., Kawakami, T., & Doorenbos, A. Z. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000876 · Cited by 43
Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm
Duke, J. W., Lewandowski, A. J., Abman, S. H., & Lovering, A. T. (2021) · The Journal of Physiology · doi:10.1113/jp281848 · Cited by 43
Prapa, M., Lago‐Docampo, M., Świetlik, E. M., Montani, D., Eyries, M., Humbert, M. J. C., Welch, C. L., Chung, W. K., Berger, R. M. F., Bogaard, H. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0485oc · Cited by 43
Self-citationKhirfan, G., Melillo, C. A., Abdi, S. A., Lane, J. E., Dweik, R. A., Chatburn, R. L., Hatipoglu, U. S., & Tonelli, A. R. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.04.002 · Cited by 42
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.